The US Food and Drug Administration has been quietly laying the groundwork for what Janet Woodcock, director of the agency’s Center for Drug Evaluation and Research, sees as the only way to resolve the growing problem of conflicting international pharmaceutical manufacturing quality requirements – establishing a global quality dossier.
“There are a lot of reasons why this should be the ultimate goal,” she told a Parenteral Drug Association meeting...





